Clinical Trial Update: Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) [Phase 2]

View source ↗

Summary

Phase 2 randomized trial evaluating withdrawal of mycophenolate mofetil in systemic lupus erythematosus was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Systemic Lupus Erythematosus, SLE | Phase 2 | Status: TERMINATED | Results posted: 2020-08-17